Gene-directed enzyme prodrug therapy (GDEPT)--recognizing the present limitations of gene therapy for the treatment of cancer.
Knox
R J
RJ
Enact Pharma plc, Salisbury, Wiltshire, UK. rknox@enactpharma.com
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015316:Genetic Therapy; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D011355:Prodrugs / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011355:Prodrugs